GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

As part of their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) can establish an infection in liver cells, researchers led by teams at Memorial Sloan ...

Dec. 3, 2024 — Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and ...

Vertical transmission of hepatitis B virus in the WHO African region: a systematic review and meta-analysis. The Lancet Global Health , 2025; 13 (3): e447 DOI: 10.1016/S2214-109X(24)00506-0 Cite ...

Get Instant Summarized Text (Gist) Research has identified a vulnerability in the hepatitis B virus (HBV) that could lead to new treatments. By disrupting the virus's ability to infect human liver ...

This is where the David Lab's expertise in how DNA gets packaged, read, and modified proved essential. They successfully generated the HBV minichromosome for the first time, using their ...

HBV母婴传播是乙肝新发感染的主要来源，全球90%的HBV感染是由于母婴传播，主要发生在HBV患病率高且资源有限的国家。2022年，全球5岁及以下儿童 ...

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. “It still feels kind of incomplete,” said ...